During the switch to metastatic cancer, tumor cells evade growth inhibitory functions of TGFβ by upregulating LIP, causing a block in C/EBPβ-induced p15INK4b activation and relieving c-Myc repression (48). This evidence concerns the gene TGFB1 and neoplasm.